European grant for ProteoNic and ORYZON

ProteoNic and ORYZON awarded European grant for joint development of cost-effective therapeutic antibodies against prostate cancer.

Leiden, Netherlands/Barcelona, Spain – ProteoNic, the protein production experts, and ORYZON genomics, the biomarker discovery company, have joined forces to develop new antibodies against prostate cancer and generate cost-effective production-ready cell lines. ProteoNic will use its expression expertise and UNic™ toolbox production yield enhancer to optimize the potential of ORYZON’s proprietary targets without compromising antibody quality. By awarding the joint venture a EuroTrans-Bio grant, the EU recognizes the unique combination of skills that will serve an unmet medical need for new prostate cancer diagnostics and treatment.

ProteoNic Receives Prestigious Frost & Sullivan Technology Innovation Award

Leiden – ProteoNic, the protein expression experts, has been awarded the Frost & Sullivan 2010 European Food Enzymes Technology Innovation Award. Frost & Sullivan recognised the company’s important contribution to cost and energy reductions in food enzyme manufacturing. It also praised its innovative technologies for enhancing production efficiency, providing the flexibility for researchers and companies to prospect nature and develop novel protein products and aid higher protein yields in a wide range of manufacturing processes.